Shenzhen Anke Completes Hundreds of Millions of Yuan in Serious B

Shenzhen Anke has recently completed hundreds of millions of yuan in Series B financing. This round of financing was led by Tongchuang Weiye, the original shareholders Shenzhen HTI Group, Maixing Investment, the new investment institution China Merchants Zhiyuan Capital, Shenzhen Venture Capital and its managed talent No. 1 fund, Jinglin Equity Fund, Baoan Guidance Fund  and Jiafa investment followed the investment.

The new round of financing will be used to increase independent innovation and research and development, to improve the global service network and management mechanism, and to upgrade related medical solutions.

Founded in 1986, Shenzhen Anke High-tech Co., Ltd. is one of the first high-tech enterprise of national excellency and

 the first medical imaging engineering center of Guangdong province and Shenzhen municipality. 

ANKE specializes in R&D, manufacturing, sales and service of medical equipments, currently including CT, MRI X-ray radiography systems,dental CT, telemedicine (Anke Image Cloud), minimally invasive surgery and other series. ANKE invented the first MRI system, spiral CT, color doppler ultrasound PACS, fetal monitor and the first surgical navigation system.All products have proprietary intellectual property rights and are IS013485 and ISO 9001 certified and approved by SFDA, CE and FDA.

ANKE has set up branches and offices throughout China and worldwide for complete sales and maintenance service system. By now, ANKE has a customer base over 10,000 hospitals. ANKE'S after-sales service enjoys a good reputation among the medical or healthcare circles. ANKE keeps a leading position in a user comprehensive satisfaction evaluation organized by the Ministry of Healthcare, which includes manufacturers of foreign brands.